Cleared Traditional

Axiostat Patch

K202830 · Advamedica, Inc. · General & Plastic Surgery
Apr 2021
Decision
202d
Days
Risk

About This 510(k) Submission

K202830 is an FDA 510(k) clearance for the Axiostat Patch, a Hemostatic Wound Dressing Without Thrombin Or Other Biologics, submitted by Advamedica, Inc. (Cambridge, US). The FDA issued a Cleared decision on April 15, 2021, 202 days after receiving the submission on September 25, 2020. This device falls under the General & Plastic Surgery review panel.

Submission Details

510(k) Number K202830 FDA.gov
FDA Decision Cleared SESE
Date Received September 25, 2020
Decision Date April 15, 2021
Days to Decision 202 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code QSY — Hemostatic Wound Dressing Without Thrombin Or Other Biologics
Device Class
Definition To Temporarily Control Bleeding And Cover External Wounds.

Similar Devices — QSY Hemostatic Wound Dressing Without Thrombin Or Other Biologics

All 125
Ganymede 2cm diameter (FG100300); Ganymede 5cm x 5cm (FG100400); Ganymede 10cm x 10cm (FG100500); Ganymede 15cm x 15cm (FG100600); Ganymede 20cm x 30cm (FG100700); Ganymede 25cm x 25cm (FG100800); Ganymede 30cm x 30cm (FG100900); Ganymede 40cm x 40cm (FG100999); Ganymede 7.5cm x 120cm (FG100100); Ganymede-X 2cm diameter (FG100301); Ganymede-X 5cm x 5cm (FG100401); Ganymede-X 10cm x 10cm (FG100501); Ganymede-X 15cm x 15cm (FG100601); Ganymede-X 20cm x 30cm (FG100701); Ganymede-X 25cm
K251700 · Speciality Fibres and Materials Limited · Feb 2026
MFUSE (MS001)
K250319 · Machina Medical, Inc. · Dec 2025
TRAUMAGEL? 2.0 Hemostatic Gel
K253609 · Cresilon, Inc. · Dec 2025
TRAUMAGEL?
K240713 · Cresilon, Inc. · Aug 2024
Polysaccharide Hemostatic Powder (HP-2, HP-3, HP-5)
K240097 · Ushare Medical, Inc. · May 2024
Hemoblock_S (Prescription); Hemoblock_S (OTC)
K232216 · Incore Co., Ltd. · Apr 2024